Private company
1Life Healthcare Inc
American Offices and Clinics of Doctors of Medicine services company1
In its 2023 annual report the company says: “We are a membership-based primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. We are disrupting health care from within the existing ecosystem by simultaneously addressing the frustrations and unmet needs of key stakeholders, which include consumers, employers, providers, and health networks.”41 It is headquartered in San Francisco, California.1
Last updated Oct 20, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Other costs97¢$1.0B
- Income tax3¢$31.5M
Out of $1.0B in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $176.8M4 | $212.7M5 | $276.3M6 | $380.2M3 | $623.3M3 | $1.0B3 | |
| Cost of revenue | $120.7M4 | $136.2M5 | $167.6M6 | $235.0M6 | $318.6M6 | ||
| Operating income | -$31.8M4 | -$45.0M5 | -$54.1M6 | -$71.4M3 | -$243.5M3 | -$419.7M3 | |
| Interest | $834.0K4 | $804.0K5 | $474.0K5 | $13.4M5 | |||
| Income before tax | -$256.4M3 | -$429.4M3 | |||||
| Income tax | $126.0K4 | $25.0K5 | $87.0K6 | -$123.0K3 | -$1.8M3 | -$31.5M3 | |
| Net income | -$30.8M4 | -$44.4M5 | -$52.6M6 | -$88.7M3 | -$254.6M3 | -$397.8M3 | |
| Earnings per share | -$2.846 | -$0.753 | -$1.643 | -$2.023 | |||
| Earnings per share (diluted) | -$2.846 | -$0.753 | -$1.643 | -$2.023 | |||
| Shares (weighted, basic) | 155.3M shares3 | 197.0M shares3 | |||||
| Shares (weighted, diluted) | 155.3M shares3 | 197.0M shares3 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $16.5M4 | $36.7M5 | $27.4M6 | $113.0M3 | $342.0M3 | $215.4M3 | |
| Receivables | $103.5M3 | $137.4M3 | |||||
| Inventory | $6.1M3 | $7.9M3 | |||||
| Current assets | $256.3M4 | $200.0M5 | $774.7M6 | $613.0M3 | $450.9M3 | ||
| Property, plant and equipment | $193.7M3 | $220.3M3 | |||||
| Goodwill | $1.1B3 | $1.2B3 | |||||
| Intangible assets | $352.2M3 | $312.2M3 | |||||
| Total assets | $326.3M4 | $430.3M5 | $1.1B6 | $2.6B3 | $2.4B3 | ||
| Accounts payable | $18.7M3 | $15.1M3 | |||||
| Current liabilities | $53.5M4 | $83.5M5 | $117.4M6 | $202.1M3 | $204.7M3 | ||
| Total liabilities | $72.1M4 | $211.8M5 | $522.5M6 | $898.4M3 | $888.7M3 | ||
| Retained earnings | -$618.2M3 | -$1.0B3 | |||||
| Shareholders’ equity | -$100.3M4 | -$119.8M5 | -$152.4M4 | -$187.1M5 | $548.5M5 | $1.7B3 | $1.5B3 |
| Shares outstanding | 18.1M shares4 | 19.0M shares5 | 134.5M shares6 | 191.7M shares3 | 206.0M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$2.7M4 | -$18.4M5 | -$31.7M6 | -$4.4M3 | -$88.6M3 | -$211.8M3 | |
| Depreciation and amortization | $46.5M3 | $91.2M3 | |||||
| Stock-based compensation | $112.3M3 | $146.9M3 | |||||
| Capital spending | $14.0M4 | $10.8M5 | $54.4M6 | $63.7M3 | $63.6M3 | $73.7M3 | |
| Free cash flow | -$16.7M | -$29.2M | -$86.1M | -$68.1M | -$152.2M | -$285.5M | |
| Cash from investing | $291.8M3 | $27.0M3 | |||||
| Share buybacks | $7.5M5 | ||||||
| Cash from financing | $27.8M3 | $61.8M3 |
Corporate structure
1Life Healthcare Inc sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of 1Life Healthcare Inc
- TIGER GLOBAL MANAGEMENT LLC Filed SC 13G/A on 1Life Healthcare Inc, latest Feb 14, 2023 (2 filings since Feb 14, 2022)
- Temasek Holdings (Private) Ltd Filed SC 13G/A on 1Life Healthcare Inc, latest Feb 10, 2023 (2 filings since Mar 4, 2022)
- VANGUARD GROUP INC Filed SC 13G/A on 1Life Healthcare Inc, latest Feb 9, 2023 (2 filings since Feb 9, 2022)
- FMR LLC Filed SC 13G/A on 1Life Healthcare Inc, latest Aug 1, 2022 (2 filings since Feb 9, 2022)
- Benchmark Capital Partners V L P Filed SC 13G/A on 1Life Healthcare Inc, latest Feb 14, 2022
- 1Life Healthcare Inc San Francisco, California
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What 1Life Healthcare Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $352.1M3 Dec 31, 2022 | $286.5M3 Dec 31, 2021 | +22.9% |
| Accumulated depreciation | $131.8M3 Dec 31, 2022 | $92.8M3 Dec 31, 2021 | +42.0% |
| Property and equipment, net | $220.3M3 Dec 31, 2022 | $193.7M3 Dec 31, 2021 | +13.7% |
| Operating-lease assets (leased space) | $276.8M3 Dec 31, 2022 | $256.3M3 Dec 31, 2021 | +8.0% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $215.4M3 Dec 31, 2022 | $342.0M3 Dec 31, 2021 | −37.0% |
| Marketable securities, current | $47.0M3 Dec 31, 2022 | $111.7M3 Dec 31, 2021 | −57.9% |
| Marketable securities, non-current | $03 Dec 31, 2022 | $48.3M3 Dec 31, 2021 | −100.0% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $1.2B3 Dec 31, 2022 | $1.1B3 Dec 31, 2021 | +0.9% |
| Intangible assets, net (excluding goodwill) | $312.2M3 Dec 31, 2022 | $352.2M3 Dec 31, 2021 | −11.4% |
| Finite-lived intangibles, gross | $371.2M3 Dec 31, 2022 | $367.0M3 Dec 31, 2021 | +1.1% |
| Accumulated amortization | $59.0M3 Dec 31, 2022 | $14.8M3 Dec 31, 2021 | +298.6% |
| Finite-lived intangibles, net | $312.2M3 Dec 31, 2022 | $352.2M3 Dec 31, 2021 | −11.4% |
Inventory
Leadership
Who has led 1Life Healthcare Inc, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerAmir Dan Rubin Jan 30, 2020 to Feb 24, 20239
- ChairAmir Dan Rubin Jan 30, 2020 to Feb 24, 20239
- PresidentAmir Dan Rubin Jan 30, 2020 to Feb 24, 20239
- Chief financial officerBjorn B. Thaler Jan 30, 2020 to Feb 24, 202310
Board members and other officers (11)
- Chief Accounting OfficerVikas Agarwal Jul 11, 2022 to Feb 24, 202311
- Chief Medical OfficerAndrew S. Diamond Jan 30, 2020 to Feb 24, 202312
- Chief Technology OfficerKimber D. Lockhart Jan 30, 2020 to Apr 22, 202113
- Board memberMary Ann Tocio Sep 3, 2021 to Feb 24, 202314
- Board memberBruce Dunlevie Jan 30, 2020 to Feb 24, 202315
- Board memberFreda C. Lewis-Hall Jan 30, 2020 to Feb 24, 202316
- Board memberHolmes Kalen Jan 30, 2020 to Feb 24, 202317
- Board memberMark S. Blumenkranz Jan 30, 2020 to Feb 24, 202318
- Board memberPaul R. Auvil Iii. Jan 30, 2020 to Feb 24, 202319
- Board memberRobert R. Schmidt Jan 30, 2020 to Jan 30, 202020
- General counselLisa A. Mango Jan 30, 2020 to Feb 24, 202321
Timeline
- Feb 22, 20238-K Results of operations22
- Feb 22, 20238-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale23
- Nov 15, 20228-K Entered a material agreement; New debt or obligation24
- Nov 2, 20228-K Results of operations25
- Sep 23, 20228-K Shareholder vote26
- Sep 7, 20228-K Other events27
- Sep 2, 20228-K Other events28
- Aug 3, 20228-K Results of operations29
- Jul 22, 20228-K Entered a material agreement; Other events30
- Jul 8, 20228-K Executive or director change31
- Jun 6, 20228-K Shareholder vote32
- May 4, 20228-K Results of operations33
- Jan 30, 2020New chief executive Amir Dan Rubin becomes CEO9
Calendar
When it reported results
- Feb 22, 2023Reported quarterly or annual results22
- Nov 2, 2022Reported quarterly or annual results25
- Aug 3, 2022Reported quarterly or annual results29
- May 4, 2022Reported quarterly or annual results33
- Feb 23, 2022Reported quarterly or annual results34
- Nov 3, 2021Reported quarterly or annual results35
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
142 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 14 major events, 91 insider forms, 9 large holders, 22 other. The latest 20:
- Mar 6, 202315-12G EDGAR
- Feb 28, 2023EFFECT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 24, 20234 PRIMARY DOCUMENT EDGAR
- Feb 22, 2023S-8 EDGAR
- Feb 22, 202310-K EDGAR
- Feb 22, 20238-K EDGAR
- Feb 22, 2023POS AM EDGAR
- Feb 22, 2023POSASR EDGAR
The 142 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
25 open-market trades by officers, directors and large owners since October 2021: 0 buys and 25 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2023 | Mango Lisa AGeneral Counsel and Secretary | Sale | 6,150 | $15.32 | $94.2K | Form 4 |
| Feb 16, 2023 | Thaler Bjorn BChief Financial Officer | Sale | 6,015 | $15.36 | $92.4K | Form 4 |
| Feb 16, 2023 | Mango Lisa AGeneral Counsel and Secretary | Sale | 7,596 | $15.36 | $116.7K | Form 4 |
| Feb 16, 2023 | Agarwal VikasChief Accounting Officer | Sale | 2,117 | $15.36 | $32.5K | Form 4 |
| Dec 20, 2022 | Thaler Bjorn BChief Financial Officer | Sale | 6,116 | $16.72 | $102.3K | Form 4 |
| Dec 1, 2022 | Thaler Bjorn BChief Financial Officer | Sale | 200 | $17.00 | $3.4K | Form 4 |
| Nov 21, 2022 | Mango Lisa AGeneral Counsel and Secretary | Sale | 4,102 | $16.58 | $68.0K | Form 4 |
| Nov 17, 2022 | Thaler Bjorn BChief Financial Officer | Sale | 761 | $16.70 | $12.7K | Form 4 |
| Nov 17, 2022 | Mango Lisa AGeneral Counsel and Secretary | Sale | 4,312 | $16.71 | $72.1K | Form 4 |
| Nov 16, 2022 | Thaler Bjorn BChief Financial Officer | Sale | 3,935 | $16.81 | $66.1K | Form 4 |
| Nov 16, 2022 | Mango Lisa AGeneral Counsel and Secretary | Sale | 4,230 | $16.82 | $71.1K | Form 4 |
| Nov 15, 2022 | Mango Lisa AGeneral Counsel and Secretary | Sale | 2,472 | $16.84 | $41.6K | Form 4 |
| Nov 1, 2022 | Thaler Bjorn BChief Financial Officer | Sale | 10,417 | $17.10 | $178.1K | Form 4 |
| Oct 24, 2022 | Diamond Andrew SChief Medical Officer | Sale | 293,185 | $17.08 | $5.0M | Form 4 |
| Oct 21, 2022 | Mango Lisa AGeneral Counsel and Secretary | Sale | 1,602 | $17.08 | $27.4K | Form 4 |
| Oct 19, 2022 | Mango Lisa AGeneral Counsel and Secretary | Sale | 2,500 | $17.06 | $42.6K | Form 4 |
| Oct 17, 2022 | Mango Lisa AGeneral Counsel and Secretary | Sale | 2,472 | $17.06 | $42.2K | Form 4 |
| Oct 7, 2022 | Rubin Amir DanChair, CEO and President | Sale | 1,371,117 | $17.03 | $23.4M | Form 4 |
| Oct 6, 2022 | Rubin Amir DanChair, CEO and President | Sale | 1,825,289 | $17.08 | $31.2M | Form 4 |
| Oct 5, 2022 | Rubin Amir DanChair, CEO and President | Sale | 2,123,402 | $17.09 | $36.3M | Form 4 |
All 25 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- TIGER GLOBAL MANAGEMENT LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202336
- Temasek Holdings (Private) LtdSC 13G/A, 2 filings Mar 4, 2022 to Feb 10, 202337
- VANGUARD GROUP INCSC 13G/A, 2 filings Feb 9, 2022 to Feb 9, 202338
- FMR LLCSC 13G/A, 2 filings Feb 9, 2022 to Aug 1, 202239
- Benchmark Capital Partners V L PSC 13G/A, 1 filing Feb 14, 202240
SEC filer profile
How 1Life Healthcare Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGAR1Life Healthcare Inc1
- CIK0001404123
- Employer ID (EIN)76-07072041
- Filer statusLarge accelerated filer1
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Industry code (SIC)8011 Services-Offices & Clinics of Doctors of Medicine1
- Business addressOne Embarcadero Center, Suite 1900, San Francisco, CA 941111
- Phone(415) 814-09271
- Shares outstanding206,538,616 as of Feb 13, 20233
- Public float$900.0M as of Jun 30, 20223
- On EDGAR sinceJun 15, 20071
- Filings390 in all: 4 (210), 8-K (34), 3 (22), 425 (16), SC 13G/A (14), 10-Q (9), DEFA14A (9), SC 13G (9)1
All 39 form types
CORRESP (7), D (6), REGDEX (5), S-8 (5), S-8 POS (5), 10-K (4), EFFECT (4), UPLOAD (3), 424B4 (2), DEF 14A (2), DRS (2), S-1 (2), SEC STAFF LETTER (2), 15-12G (1), 25-NSE (1), 424B3 (1), 5 (1), 8-A12B (1), 8-K/A (1), CERT (1), DEFM14A (1), DRS/A (1), DRSLTR (1), POS AM (1), POSASR (1), PREM14A (1), S-1/A (1), S-1MEF (1), S-3ASR (1), S-4 (1), S-4/A (1)
- Latest filingsAnnual report (10-K) Feb 22, 2023
Quarterly report (10-Q) Nov 2, 2022
Proxy statement (DEF 14A) Apr 21, 2022
Latest 8-K (8-K) Feb 22, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARMary Ann Tocio, Board member
- 15SEC EDGARBruce Dunlevie, Board member
- 16SEC EDGARFreda C. Lewis-Hall, Board member
- 17SEC EDGARHolmes Kalen, Board member
- 18SEC EDGARMark S. Blumenkranz, Board member
- 19SEC EDGARPaul R. Auvil Iii., Board member
- 20SEC EDGARRobert R. Schmidt, Board member
- 21SEC EDGARLisa A. Mango, General counsel
- 22SEC EDGARResults of operations
- 23
- 24
- 25SEC EDGARResults of operations
- 26SEC EDGARShareholder vote
- 27SEC EDGAROther events
- 28SEC EDGAROther events
- 29SEC EDGARResults of operations
- 30
- 31SEC EDGARExecutive or director change
- 32SEC EDGARShareholder vote
- 33SEC EDGARResults of operations
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41